290 results on '"Comai, Stefano"'
Search Results
2. Activation of Kv7 channels normalizes hyperactivity of the VTA-NAcLat circuit and attenuates methamphetamine-induced conditioned place preference and sensitization in mice
3. Therapeutic modulation of the kynurenine pathway in severe mental illness and comorbidities: A potential role for serotonergic psychedelics
4. Esmethadone-HCl (REL-1017): a promising rapid antidepressant
5. Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies
6. Substantially elevated serum glutamate and CSF GOT-1 levels associated with cerebral ischemia and poor neurological outcomes in subarachnoid hemorrhage patients
7. The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy
8. Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study
9. Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline
10. Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
11. Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression
12. Melatonin Regulates Neuronal Synaptic Plasticity in the Supramammillary Nucleus and Attenuates Methamphetamine‐Induced Conditioned Place Preference and Sensitization in Mice.
13. Dysfunction of the serotonergic system in the brain of synapsin triple knockout mice is associated with behavioral abnormalities resembling synapsin-related human pathologies
14. Selective Enhancement of REM Sleep in Male Rats through Activation of Melatonin MT1 Receptors Located in the Locus Ceruleus Norepinephrine Neurons.
15. Prenatal IL-6 levels and activation of the tryptophan to kynurenine pathway are associated with depressive but not anxiety symptoms across the perinatal and the post-partum period in a low-risk sample
16. Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder
17. Role of palmitoylethanolamide (PEA) in depression: Translational evidence: Special Section on “Translational and Neuroscience Studies in Affective Disorders”. Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders
18. Trace elements among a sample of prisoners with mental and personality disorders and aggression: correlation with impulsivity and ADHD indices
19. Lifetime Cannabis Use Disorder Is Not Associated With Lifetime Impulsive Behavior and Severe Violence in Patients With Schizophrenia Spectrum Disorders From a High-Security Hospital
20. Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease
21. Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality Disorders.
22. Tryptophan via serotonin/kynurenine pathways abnormalities in a large cohort of aggressive inmates: markers for aggression
23. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
24. Age-related effects of exogenous melatonin on anxiety-like behavior in C57/B6J mice
25. Antidepressant combination versus antidepressants plus second-generation antipsychotic augmentation in treatment-resistant unipolar depression
26. The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users.
27. Psychopathological and sociodemographic features in treatment-resistant unipolar depression versus bipolar depression: a comparative study
28. THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLD
29. Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam
30. Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome.
31. Biological Factors Underpinning Suicidal Behaviour: An Update.
32. CCNP Award Paper: Unveiling the role of melatonin [MT.sub.2] receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology
33. Centella asiatica (L.) urban from Nepal: Quali-quantitative analysis of samples from several sites, and selection of high terpene containing populations for cultivation
34. Antinociceptive properties of selective MT2 melatonin receptor partial agonists
35. A DROSOPHILA APPROACH TO STUDY THE EFFECTS OF ATYPICAL ANTIPSYCHOTIC DRUGS
36. Sex Differences in Responses to Antidepressant Augmentations in Treatment-Resistant Depression.
37. Melatonin and aggressive behavior: A systematic review of the literature on preclinical and clinical evidence.
38. Protein and non-protein (free and protein-bound) tryptophan in legume seeds
39. The content of proteic and nonproteic (free and protein-bound) tryptophan in quinoa and cereal flours
40. Sleep-wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice
41. Distinct Effects of Antidepressants in Association With Mood Stabilizers and/or Antipsychotics in Unipolar and Bipolar Depression.
42. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C
43. Ventricular cerebrospinal fluid melatonin concentrations investigated with an endoscopic technique
44. A Study of Tryptophan Metabolism via Serotonin in Ventricular Cerebrospinal Fluid in HIV-1 Infection Using a Neuroendoscopic Technique
45. Cloricromene effect on the enzyme activities of the tryptophan–nicotinic acid pathway in diabetic/hyperlipidemic rabbits
46. Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice.
47. Melatonin recovers sleep phase delayed by MK‐801 through the melatonin MT2 receptor‐ Ca2+‐CaMKII‐CREB pathway in the ventrolateral preoptic nucleus.
48. Dysfunction of serotonergic activity and emotional responses across the light‐dark cycle in mice lacking melatonin MT2 receptors.
49. Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide.
50. Novel selective melatonin MT2 receptor agonist in the treatment of insomnia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.